Finance

Chicagoans Face Healthcare Crisis as ACA Subsidies End
Management & Administration Chicagoans Face Healthcare Crisis as ACA Subsidies End

As a critical pandemic-era relief measure comes to a close, hundreds of thousands of Chicago and Illinois residents are on the brink of a healthcare crisis that threatens to unravel years of progress in public health. The scheduled expiration of enhanced federal subsidies for Affordable Care Act

Is AI the Cure for Hospital Revenue Woes?
Tech & Innovation Is AI the Cure for Hospital Revenue Woes?

With a deep background in robotics and IoT applications in medicine, James Maitland has a unique vantage point on the technological currents reshaping the healthcare industry. He joins us today to dissect the rapid, and sometimes hesitant, adoption of artificial intelligence in a hospital's most

McElroy & Associates Breach Exposes Health and Financial Data
Management & Administration McElroy & Associates Breach Exposes Health and Financial Data

The convergence of sensitive personal health and financial data within a single system creates a high-value target for cybercriminals, making any security lapse a potentially life-altering event for those whose information is exposed. McElroy & Associates, Inc., which administers the OPEH&W Health

How Can Systems of Excellence Transform Population Health?
Management & Administration How Can Systems of Excellence Transform Population Health?

The American healthcare landscape is currently grappling with an unsustainable paradox, where remarkable medical advancements coexist with a failing system for managing the very chronic diseases that affect the majority of the population. This "sick-care" model, which prioritizes reactive

Is It Time to Replace Obamacare with Patient Control?
Management & Administration Is It Time to Replace Obamacare with Patient Control?

American health care policy has arrived at a critical crossroads, forcing a legislative showdown between two fundamentally different visions for its future that will shape access, cost, and control for millions. Lawmakers must now decide whether to once again extend the enhanced premium subsidies

How Will SUD Treatment Prove Its Value in 2026?
Management & Administration How Will SUD Treatment Prove Its Value in 2026?

The year 2026 is poised to be a watershed moment for the substance use disorder (SUD) treatment industry, compelling providers to fundamentally redefine their value proposition amid unprecedented market and policy pressures. Following a tumultuous 2025 characterized by investor hesitation,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later